Topics

Companies Related to "Tumor Growth Factors in Hepatocellular Carcinoma" [Most Relevant Company Matches] RSS

08:36 EST 14th November 2019 | BioPortfolio

Here are the most relevant search results for "Tumor Growth Factors in Hepatocellular Carcinoma" found in our extensive corporate database of over 50,000 company records.

Showing "Tumor Growth Factors Hepatocellular Carcinoma" Companies 1–25 of 2,100+

Extremely Relevant

Kite Pharma, Inc.

Kite Pharma, Inc. is a privately held development stage biotechnology company engaged in the design and development of cutting-edge immunotherapeutic products to treat different cancer indications. Kite's lead products include antigens associated with a wide variety of tumor types, and are initially being developed for the treatment of renal cell carcinoma...


Relevant

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like grow...

Phoenix Pharmacologics Inc.,

Phoenix Pharmacologics Inc., with its principal headquarterslocated in, San Diego, California, is a privately-held emerging biopharmaceutical company that specializes in developing drugs to treat cancer and related disorders. Two of its protein drugs are in late stage clinical trials: ADI-PEG 20 for the treatment of hepatocellular carcinoma and metastatic melanoma,and Uricase-PEG 20 for the treatm...


AVEO Pharmaceuticals Inc.

AVEO Pharmaceuticals is a biopharmaceutical company seeking to advance targeted medicines for oncology and other unmet medical needs. The Company’s lead candidate is tivozanib, a potent, selective, long half-life inhibitor of vascular endothelial growth factor 1, 2 and 3 receptors, which AVEO is working to develop and commercialize in North America as a treatment for renal cell carcinoma (RC...

Oncomatrix

Oncomatrix is focused on the development of new biopharmaceuticals targeting the tumor stroma. This innovative approach aims not to attack the tumor cells directly but rather the cells supporting the growth and invasiveness of the tumor.

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...

IBT

ibt develops, manufactures and distributes reagents (monoclonal and polyclonal antibodies, proteins, peptides, antigens) for infectious disease research, transcription, growth factor and cytokine research and assay kits for the detection of growth factors, e.g. insulin-like growth factors (IGF´s) and insulin-like growth factor binding proteins (IGFBP´s).

Biomedical Technologies Incorporated

BTI Cell Growth Factors & Attachment Factors, BTI Immunoassay Kits, BTI Cell Culture Additives & Components, BTI Lipoproteins/Proteins, BTI Antibodies, BTI [I125] Labeled Compounds & Custom [I125] Radioiodinations.

Pharmablood

PharmaBlood performs R&D of personalized medical treatment methods using as therapeutic agents autologous blood derivative compositions in cancer patients.PharmaBlood is a trademark of Telemedical Organization Inc used to identify the activity of the company in the field of research and development of blood derivatives as medical therapeuticals.Telemedical Organization Inc is an American company w...

Scil Technology GmbH

Scil Technology develops unique biomaterials that integrate bone or cartilage growth factors and synthetic scaffolds or implants. In this way, the Company combines the very best of prosthetic and bone augmentation technologies with pioneering regenerative medicine. What sets Scil Technology further apart is its proprietary protein coating technology that allows for a highly stable and homogeneous ...

Antigenix

ANTIGENIX AMERICA provides monoclonal and polyclonal antibodies to CD markers, cytokines, growth factors, adhesion markers, and viral proteins for immunology research in Human, Mouse, Rat, Rabbit, and Pig models. In addition, a full selection of recombinant cytokines and growth factors are provided, including cytokine ELISA kits, and matched antibody pairs for ELISA development. Custom Immunology ...

Biomed Comm Incorporated

Biomed Comm TM (BMC) was founded in May 1996 to manufacture Dr.Brewitt's proprietary growth factor products known as Cell Signal Enhancers® (CSE®). The company's homeopathic growth factors represent a new class of medicines combining today's advanced biotechnologies, electro-magnetic field theory and basic homeopathic principles formed over two centuries ago. Biomed CommTM currently manufact...

Mendel Biotechnology, Inc

Mendel Biotechnology was founded in early 1997 to develop the idea that controlling gene expression would create new opportunities to improve plant growth and development. We have focused on a large class of genes called transcription factors because they control the degree to which each gene in a cell is activated. The approximately 27,000 genes in the Arabidopsis genome are controlled by approxi...

MetaMorphix, Inc.

MetaMorphix Inc. was formed in 1994 as a research collaboration between Genetics Institute, now a part of Wyeth (a pharmaceutical company) and the Johns Hopkins School of Medicine. The purpose of the collaboration was to discover and characterize Growth Differentiation Factors. The collaboration discovered 16 unique growth factors. MetaMorphix's initial platform technology is based on one of these...

AdnaGen AG

AdnaGen's diagnostics detect circulating tumor cells in tumor patients. Because tumor cells survive only hours in the bloodstream, there must be an active source, e.g. a relapse or a metastasis. Therefore, the presence of circulating tumor cells is an unfavorable indicator for the progress of the tumor disease. AdnaGen's proprietary 'combination-of-combinations-principle' allows the reliable and v...

FLX Bio, Inc.

FLX475 is a best-in-class oral, small molecule antagonist of CCR4. CCR4 ligands are elevated in multiple tumor types when compared to normal tissue. In preclinical studies, FLX475 inhibited tumor growth and increased tumor regression. In addition, FLX475 enhanced the antitumor effects of various checkpoint inhibitors including anti-PD-L1 and anti-CTLA4 ant...

Provectus Biopharmaceuticals, Inc.

Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. Its novel oncology drug PV-10 is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer and cancers of the liver....

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. is a specialty pharmaceutical company whose mission is to greatly extend the lives of patients with solid tumor cancers. Intensity Therapeutics is pioneering a new approach to treat cancer referred to as in situ chemovaccination. The Company creates novel, proprietary formulations of proven chemotherapy drugs. These products, w...

National Brain Tumor Society (NBTS)

National Brain Tumor Society is the largest nonprofit organization dedicated to the brain tumor community in the United States. We are fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and those who will be diagnosed tomorrow. This means aggressively driving strategic research and advocati...

Attenuon, LLC

Attenuon, LLC is a San Diego-based clinical-stage biopharmaceutical company developing a new generation of cancer therapeutics. Attenuon’s drug candidates are designed to selectively disrupt multiple cellular processes important to tumor growth and metastasis (the spreading of tumors). Rather than indiscriminately killing both malignant and normal cells undergoing cell division, these drugs are ...

Immunotech

Immunoassay of HIV, SIV, Histamine, cytokines and growth factors Monoclonal antibodies for use in immunohistochemsitry and researchantibodies to human and mouse antigens and antibodies for immunohistochemistry

ARP American Research Products, Inc.TM

ARP American Research Products, Inc. TM has developed a worldwide reputation for providing its customers with research and diagnostic tools of the highest quality. We are dedicated to the development of biological and biomedical research products, which are distributed in countries all over the globe. We offer Monoclonal and Polyclonal Antibodies as well as purified and recombinant Antigens for re...

Caprologics

Capralogics has manufactured a variety of novel polyclonal antibodies against Cell Membrane Receptors, Nuclear Components, Apoptosis Factors, Neuropeptides, Oncoproteins, Signaling Intermediates, Transcription Factors and Proteins Involved in Infectious D

Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing targeted cancer therapies for people living with genetically defined cancers. Ayala is broadly developing its product candidates, AL101 and AL102, best-in-class gamma secretase inhibitors, with clinical and nonclinical studies underway in both solid tumors (AL...

Phoenix Biotechnology, Inc.

Phoenix Biotechnology, Inc., a San Antonio, Texas based biotechnology company, was incorporated in Texas in 2003 to develop promising agents with minimal or no side effects for targeted therapy of malignant tumor growth. Targeted therapy has recently become the focus in the medical community for the treatment of oncologic diseases. Pharmaceutical companies...


More From BioPortfolio on "Tumor Growth Factors in Hepatocellular Carcinoma"

Quick Search

Corporate Database Quicklinks